Business
Brooks Automation Reports Results of Third Quarter of Fiscal 2021, Ended June 30, 2021, and Announces Quarterly Cash Dividend
Robust Demand and Strong Execution Drive Continued Growth in Revenue and Profitability CHELMSFORD, Mass., Aug. 5, 2021 /PRNewswire/ -- Brooks Automation, Inc.
About this update from Azenta, Inc.
[{"type":"text","content":"Robust Demand and Strong Execution Drive Continued Growth in Revenue and Profitability\n\n\nCHELMSFORD, Mass., Aug. 5, 2021 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fiscal quarter ended June 30, 2021.\nFinancial Results Summary\nQuarter Ended\nDollars in millions, except per share data\nJune 30, \nMarch 31, \nJune 30, \nChange vs.\n2021\n2021\n2020\nPrior Qtr\nPrior Year\nRevenue\n$\n315\n$\n287\n$\n220\n10\n%\n43\n%\nSemiconductor Solutions \n$\n186\n$\n157\n$\n127\n19\n%\n47\n%\nLife Sciences \n$\n129\n$\n130\n$\n93\n0\n%\n38\n%\nDiluted EPS Continuing Operations\n$\n0.53\n$\n0.32\n$\n0.19\n64\n%\n184\n%\nDiluted EPS Total\n$\n0.53\n$\n0.32\n$\n0.19\n65\n%\n184\n%\nNon-GAAP Diluted EPS Continuing Operations\n$\n0.72\n$\n0.61\n$\n0.32\n17\n%\n127\n%\nAdjusted EBITDA\n$\n78\n$\n71\n$\n40\n10\n%\n94\n%\nManagement Comments \n\"We are proud of the results of our third fiscal quarter with strong execution by both businesses,\" commented Steve Schwartz, President and CEO. \"Life Sciences sustained its high growth performance and Semiconductor Solutions acceleration was exceptionally strong. We expect our fourth fiscal quarter of 2021 to continue the upward trajectory. We remain on track for the planned separation into two standalone companies, which is expected to occur by the end of the calendar year.\"\nSummary of GAAP Results\nThird Quarter, Fiscal 2021\nRevenue for the third quarter was $315 million, up 43% year over year driven by growth in both Life Sciences and Semiconductor Solutions. Diluted EPS from continuing operations was $0.53 per share compared to $0.19 per share in the third quarter of 2020. Life Sciences revenue of $129 million grew 38% year over year. Year-over-year organic growth was 42%. Life Sciences Products grew 60% year over year, and Life Sciences Services grew 28%. Excluding the effect of the recent exit of the RUCDR alliance, Life Science Services grew 43%. Semiconductor Solutions revenue was $186 million, an increase of 47% year over year. Year-over-year organic growth was 43%. Operating income was $50 million, compared to $19 million in the third quarter of 2020. Operating margin was 15.9%, up 730 basis points year over year and was driven by gross margin of 45.8%, up 370 basis points year over year. Operating expenses in the quarter include approxim...